Loading...
HomeMy WebLinkAbout2025-490-E-Health Dept-Freedom House-Services and support programs that serve persons with Opioid Use DisorderOrange County Opioid Funding Agency Performance Agreement Revised 07/25 Page 1 of 10 OPIOID FUNDING AGENCY PERFORMANCE AGREEMENT THIS AGREEMENT, made and entered into the first day of July 2025, (“Effective Date”) by and between the County of Orange, a political subdivision of the State of North Carolina, Post Office Box 8181, Hillsborough, North Carolina, 27278, ("County") and Freedom House Recovery Center, Inc., a non-profit corporation located at 104 New Stateside Drive, Chapel Hill, North Carolina 27516 (“Provider”). WITNESSETH: WHEREAS, it is in the interests of the County that said program be assisted by the County and thereby enhance its availability to residents of the County, and said program addresses an important community human services need, as identified by the Board of Commissioners. NOW, THEREFORE, in consideration of the above and the mutual covenants and conditions hereafter set forth, the County and Provider agree as follows: 1. Term of the Agreement. The term of this Agreement shall be a program year beginning July 1, 2025 to June 30, 2026. 2. Scope of Services. a. Provider will provide services, as outlined in Exhibit A to NC MOA: High-Impact Opioid Abatement Strategies (“OPTION A” List) - to the residents of Orange County. The Scope of Services and the Program Budget (Exhibit B) may be different from the original application based on County appropriation; however, any revisions or amendments to this Agreement must be approved in writing by the County and attached to this Agreement as Exhibit C. b. The Provider shall be solely responsible for the means, methods, techniques, sequence, safety program and procedures necessary to properly and fully complete the work set forth in the Scope of Services. 3. Funding. a. The County agrees to appropriate for the provision of services described in Exhibit B, Scope of Services and more particularly described in the Revised Program Budget, the maximum sum of $66,423.00. b. All funds appropriated shall be used for purposes described in Scope of Services. Any funds not used for the purposes stated shall be returned to the County. Any changes in the use of funds must be authorized in writing by the County prior to any expenditure of the funds by the Provider. If the funds are expended not in accordance with the Scope of Services, at the discretion of the County the Provider may be required to repay the funds to the County. c. The Provider shall be paid in four equal installments in the amount of $16,605.75. The first payment is contingent upon receipt of the agency’s performance agreement; the remaining payments are contingent upon receipt of the request for reimbursement and related supporting documentation. d. The County’s obligation to make the quarterly payments is contingent upon receipt of Progress Reports (Attachment A), which show satisfactory progress toward completion of performance measures and an accounting of expenditures as detailed in the Scope of Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Orange County Opioid Funding Agency Performance Agreement Page 2 of 10 Rev.07/25 Services. Final payment is contingent upon a final Progress Report as well as the narrative story and accounting of expenditures. e. Once Provider has satisfied its obligations as provided in (d) payment will be made 21 days after receipt of the Progress Report and Request for Reimbursement or 21 days after due date of Progress Report whichever is later. f. The County is not obligated to provide any other support to Provider in this or in succeeding fiscal years. 4. Agency Reporting. a. Provider will provide Orange County a Progress Report that includes a fiscal report and updates on performance measures as outlined in the Scope of Services. • Progress Report dates are: January 10 for reporting months July 1 - December 31 • April 10 for reporting months January 1 - March 31 • July 10 for reporting months April 1 – June 30 b. Provider agrees to allow the County to inspect its financial books and records, which document costs of those services, upon reasonable notice during normal working hours. 5. Termination. a. Termination for Cause. In the event of any of the circumstances set forth below (hereinafter referred to as “default”), the County may immediately terminate this Agreement, in whole or in part, and from time to time. Notice of termination must be in writing, state the reason or reasons for the termination, and specify the effective date of the termination: i. In the event that Provider shall cease to exist as an organization or shall enter bankruptcy proceedings, be declared insolvent, or liquidate all or substantially all of its assets, or significantly reduce its services or accessibility to Orange County residents during the term of this Agreement; or ii. In the event that Provider shall fail to render a satisfactory accounting as provided section 4 above, the County may terminate this Agreement and Provider shall return all payments already made to it by the County for services which have not been provided or for which no satisfactory accounting has been rendered; or iii. In the event of any fraudulent representation by the Provider in an invoice or other verification required to obtain payment under this Agreement or other dishonesty on a material matter relating to the performance of services under this Agreement. iv. Nonperformance, incomplete service or performance, or failure to satisfactorily perform any part of the work identified in the Scope of Services or to comply with any provision of this Agreement, as determined by the County in its sole discretion. v. Failure to adhere to the terms of applicable county, state or federal laws, regulations, or stated public policy. b. In the event of default by the Provider, the county may elect to terminate this Agreement, in whole or in part and/or require the Provider to repay the funds within ten (10) business days from written notice of default. The County may (but shall not be required to) grant the Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Orange County Opioid Funding Agency Performance Agreement Page 3 of 10 Rev.07/25 Provider an opportunity to cure the default without termination of this Agreement. This clause shall not be interpreted to limit the County’s remedies in law or in equity. c. Notwithstanding the foregoing, either party may terminate the agreement at any time without penalty; provided that written notice of such termination is furnished to the other party at least 30 days prior to termination. In the event of such termination, any payment due shall be prorated to the date of termination and any unused funds shall be returned to the County within 10 days of termination. d. Any termination of this Agreement for default under this section that is later deemed to be unjustified shall be deemed a termination for convenience. e. Waiver. The payment of any sums by the County under this Agreement or the failure of the County to require compliance by the Provider with any provisions of this Agreement or the waiver by the County of any breach of this Agreement shall not constitute a waiver of any claim for damages by the County for any breach of this Agreement or a waiver of any other required compliance with this Agreement. 6. Responsibilities of the County. Cooperation and Coordination. The County has designated (Orange County Health Director, Quintana Stewart) to act as the County's representative with respect to the Project who shall have the authority to render decisions within guidelines established by the County Manager or the County Board of Commissioners and who shall be available during working hours as often as may be reasonably required to render decisions and to furnish information. 7. Insurance. a. General Requirements. Provider shall obtain, at its sole expense, Commercial General Liability Insurance, Automobile Insurance, Workers’ Compensation Insurance, and any additional insurance as may be required by County’s Risk Manager as such insurance requirements are described in the Orange County Risk Transfer Policy and Orange County Minimum Insurance Coverage Requirements (each document is incorporated herein by reference and may be viewed at http://www.orangecountync.gov/departments/purchasing_division/contracts.php). If County’s Risk Manager determines additional insurance coverage is required such additional insurance shall consist of Professional Liability and Molestation/Sexual Assault rider (if no additional insurance required mark N/A as being not applicable). Provider shall not commence work until such insurance is in effect and certification thereof has been received by the County's Risk Manager. a. Nothing in this section is intended to affect or abrogate the County’s sovereign immunity defenses. 8. General Provisions. a. Governing Law. This Agreement and the duties, responsibilities, obligations and rights of respective parties hereunder shall be governed by the laws of the State of North Carolina. By executing this Agreement Provider affirms that Provider and any subcontractors of Provider are and shall remain in compliance with Article 2 of Chapter 64 of the North Carolina General Statutes. By executing this Agreement Provider certifies that Provider has not been identified, and has not utilized the services of any agent or subcontractor identified, on the list created by the State Treasurer pursuant to G.S. 147-86.58. By executing this Agreement Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Orange County Opioid Funding Agency Performance Agreement Page 4 of 10 Rev.07/25 Provider certifies that Provider has not been identified, and has not utilized the services of any agent or subcontractor identified, on the list created by the State Treasurer pursuant to G.S. 147-86.81. b. Non-Discrimination. Provider agrees as part of consideration of the granting of funds by Orange County the parties hereto for themselves, their agents, officials, employees and servants agree not to discriminate in any manner of these basis of race, color, gender, national origin, age, handicap, religion, sexual orientation, familial status or veterans status with reference to any activities carried out by the grantee, no matter how remote. The parties hereto further agree in all respects to conform to the provision and intent of Orange County Civil Rights Ordinance, as amended and the Orange County Non-discrimination Policy, which is incorporated herein by reference and can be viewed at http://www.orangecountync.gov/departments/purchasing_division/contracts.php. The County may enforce this provision by an action for specific performance, injunctive relief, or other remedy as by law provided; this provision shall be binding on the grantees, the successors and assigns of the parties hereto with reference to the above subject manner. c. Dispute Resolution. Any and all suits or actions to enforce, interpret or seek damages with respect to any provision of, or the performance or non-performance of, this Agreement shall be brought in the General Court of Justice of North Carolina sitting in Orange County, North Carolina. It is agreed by the parties that no other court shall have jurisdiction or venue with respect to such suits or actions. Binding arbitration may not be initiated by either Party, however, the Parties may agree to nonbinding mediation of any dispute prior to the bringing of such suit or action. d. Relationship of the Parties. Provider is an independent contractor of the County. Provider represents that they have or will secure, at his own expense, all personnel required in performing the services under this Agreement. Such personnel shall not be employees or have any contractual relationship with the County. All personnel engaged in work under this Agreement shall be fully qualified and shall be authorized and permitted under federal, state and local law to perform such services. e. Compliance with all Laws. The Provider, at its sole expense, shall comply with all laws, ordinances, orders and regulations of the federal, state or local governments, as well as their respective departments, commissions, boards, and officers, which are in effect at the time of execution of this Agreement or are adopted at any time following execution of this agreement. f. Subcontract. The County and Provider deem the services provided under this Agreement to be personal in nature and Provider may not subcontract any rights or duties under this Agreement to any other party without prior written consent from the County. g. Assignment. The Provider shall not assign this Agreement, including the rights to payment, to any other party without the prior written consent of the County. h. Indemnification. Provider agrees to defend, indemnify, and hold harmless the County, for all loss, liability, claims or expense (including reasonable attorney's fees) arising from bodily injury, including death or property damage, to any person or persons caused in whole or in part by the negligence or willful misconduct of the Provider, except to the extent same are caused by the negligence or willful misconduct of the County. It is the intent of this section to require Provider to indemnify the County to the extent permitted under North Carolina Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Orange County Opioid Funding Agency Performance Agreement Page 5 of 10 Rev.07/25 law. Nothing in this section is intended to affect or abrogate the County’s sovereign immunity defenses. i. Non-Appropriation. This Agreement is subject to the availability of funds to purchase the specified services and may be terminated at any time if such funds become unavailable. j. Severability. All clauses found herein shall act independently of each other. If a clause is found to be illegal or unenforceable, it shall have no effect on the other provisions of this Agreement. It is understood by the parties hereto that if any part, term or provision of this Agreement is by the Courts held to be illegal or in conflict with any laws of the State of North Carolina or the United States, the validity of the remaining portions or provisions shall not be affected, and the rights and obligations of the parties shall be construed and enforced as if the Agreement did not contain the particular part, term or provision held to be invalid. k. Entire Agreement. This Agreement represents the entire and integrated agreement between the County and the Provider and supersedes all prior negotiations, representations or agreements, either written or oral. This Agreement may be amended only by written instrument signed by both parties. Modifications may be evidenced by facsimile signatures. l. Notices. Any notice required by this Agreement shall be in writing and delivered by certified or registered mail, return receipt requested to the following: Orange County Provider’s Name: Freedom House Recovery Center Attention: Kimberlee Quatrone Attention: Joyce Harper P.O. Box 8181 Address: 104 New Stateside Drive Hillsborough, NC 27278 Chapel Hill, NC 27516 Email:kquatrone@orangecountync.gov Email: Joyce.H@FreedomHouseRecovery.org m. Signatures. This Agreement together with any amendments or modifications may be executed electronically. All electronic signatures affixed hereto evidence the intent of the Parties to comply with Article 11A and Article 40 of North Carolina General Statute Chapter 66. IN WITNESS WHEREOF, the Orange County and the Provider have signed this Agreement, effective on the last date this Agreement is signed by both parties as indicated by the dates set forth under signatures below. For and on behalf of the Provider _____________________________ _______________________ Joyce Harper, CEO Date For and on behalf of Orange County Government _______________________________ ________________________ Travis Myren, County Manager Date Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 8/8/2025 8/12/2025 Orange County Opioid Funding Agency Performance Agreement Page 6 of 10 Rev.07/25 ORANGE COUNTY—INTERNAL USE ONLY ______________________________________________________________________________ Finance Information Vendor Name: Freedom House Vendor Contact Person: Joyce Harper Phone: 919-942-2803 Address: 104 New Stateside Drive City Chapel Hill State: NC Zip: 27516 Department: Health Amount: $66,423.00 Purpose: Services and support programs that serve persons with Opioid Use Disorder Budget Code(s): 27411020-630000-92001 Vendor # 34104 Vendor Status with NCSOS: Current-Active Non-Profit Vendor is a BOCC consultant: Yes No Contract Details Contract Type: New Amendment (Original Contract: ) (Most Recent Amendment ) Effective Date 7-1-25 End Date 6-30-26 Notice Date (Notice Purpose ) Award Approved by Board (Agenda Date: May 20, 2025); Made or Administered by Signature Authority - BOCC Express Delegation (Agenda Date: ) - Policy 9.4: Under $5,000; Service Under $90,000; Construction Under $250,000 - Budget Policy Section XV (Capital Improvement Project: ) Bidding Informal Bidding ($30k-$90k); Formal RFP ($90k+); Other (<$30k); Exception(# ) Department Affirmation This agreement is approved as to technical form and content and I as Department Director affirmatively state work on this project has not been initiated prior to execution of the agreement. Services related to this agreement have already begun or been completed. Description of the nature of the emergency condition that was addressed: Department Director’s Signature ________________________________________ Date: ________ Information Technologies This agreement has been reviewed and is approved as to information technology content and specifications: Office of the Chief Information Officer___________________________________ Date: ________ Inapplicable because no hardware/software purchases or related services Risk Management This agreement is approved for sufficiency of insurance standards, specifications, and requirements: Office of the Risk Management Officer___________________________________ Date: _________ Financial Services This instrument has been pre-audited in the manner required by the Local Government Budget and Fiscal Control Act: Office of the Chief Financial Officer ____________________________________ Date: _________ Legal Services This agreement is approved as to legal form and sufficiency: Office of the County Attorney __________________________________________Date: ________ Clerk to the Board All Docusign contracts must be copied to the Clerk upon completion: occlerkdocs@orangecountync.gov The following signature block is for hard copies only and is not required for Docusign contracts: Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 8/11/2025 8/11/2025 8/12/2025 8/12/2025 Orange County Opioid Funding Agency Performance Agreement Page 7 of 10 Rev.07/25 Received for record retention: Office of the Clerk to the Board __________________________________________Date:_________ Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Exhibits, page 1 EXHIBIT A TO NC MOA: HIGH-IMPACT OPIOID ABATEMENT STRATEGIES (“OPTION A” List) In keeping with the National Settlement Agreement, opioid settlement funds may support programs or services listed below that serve persons with Opioid Use Disorder (OUD) or any co-occurring Substance Use Disorder (SUD) or mental health condition. As used in this list, the words “fund” and “support” are used interchangeably and mean to create, expand, or sustain a program, service, or activity. 1.Collaborative strategic planning. Support collaborative strategic planning to address opioid misuse, addiction, overdose, or related issues, including staff support, facilitation services, or any activity or combination of activities listed in Exhibit C to the MOA (collaborative strategic planning). 2.Evidence-based addiction treatment. Support evidence-based addiction treatment consistent with the American Society of Addiction Medicine’s national practice guidelines for the treatment of opioid use disorder – including Medication-Assisted Treatment (MAT) with any medication approved for this purpose by the U.S. Food and Drug Administration – through Opioid Treatment Programs, qualified providers of Office-Based Opioid Treatment, Federally Qualified Health Centers, treatment offered in conjunction with justice system programs, or other community-based programs offering evidence-based addiction treatment. This may include capital expenditures for facilities that offer evidence-based treatment for OUD. (If only a portion of a facility offers such treatment, then only that portion qualifies for funding, on a pro rata basis.) 3.Recovery support services. Fund evidence-based recovery support services, including peer support specialists or care navigators based in local health departments, social service offices, detention facilities, community-based organizations, or other settings that support people in treatment or recovery, or people who use drugs, in accessing addiction treatment, recovery support, harm reduction services, primary healthcare, or other services or supports they need to improve their health or well-being. 4.Recovery housing support. Fund programs offering recovery housing support to people in treatment or recovery, or people who use drugs, such as assistance with rent, move-in deposits, or utilities; or fund recovery housing programs that provide housing to individuals receiving Medication-Assisted Treatment for opioid use disorder. 5.Employment-related services. Fund programs offering employment support services to people in treatment or recovery, or people who use drugs, such as job training, job skills, job placement, interview coaching, resume review, professional attire, relevant courses at community colleges or vocational schools, transportation services or transportation vouchers to facilitate any of these activities, or similar services or supports. 6.Early intervention. Fund programs, services, or training to encourage early identification and intervention for children or adolescents who may be struggling with problematic use of drugs or mental health conditions, including Youth Mental Health Exhibit ADocusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Exhibits, page 2 First Aid, peer-based programs, or similar approaches. Training programs may target parents, family members, caregivers, teachers, school staff, peers, neighbors, health or human services professionals, or others in contact with children or adolescents. 7. Naloxone distribution. Support programs or organizations that distribute naloxone to persons at risk of overdose or their social networks, such as Syringe Service Programs, post-overdose response teams, programs that provide naloxone to persons upon release from jail or prison, emergency medical service providers or hospital emergency departments that provide naloxone to persons at risk of overdose, or community-based organizations that provide services to people who use drugs. Programs or organizations involved in community distribution of naloxone may, in addition, provide naloxone to first responders. 8. Post-overdose response team. Support post-overdose response teams that connect persons who have experienced non-fatal drug overdoses to addiction treatment, recovery support, harm reduction services, primary healthcare, or other services or supports they need to improve their health or well-being. 9. Syringe Service Program. Support Syringe Service Programs operated by any governmental or nongovernmental organization authorized by section 90-113.27 of the North Carolina General Statutes that provide syringes, naloxone, or other harm reduction supplies; that dispose of used syringes; that connect clients to prevention, treatment, recovery support, behavioral healthcare, primary healthcare, or other services or supports they need; or that provide any of these services or supports. 10. Criminal justice diversion programs. Support pre-arrest or post-arrest diversion programs, or pre-trial service programs, that connect individuals involved or at risk of becoming involved in the criminal justice system to addiction treatment, recovery support, harm reduction services, primary healthcare, prevention, or other services or supports they need, or that provide any of these services or supports. 11. Addiction treatment for incarcerated persons. Support evidence-based addiction treatment, including Medication-Assisted Treatment with at least one FDA-approved opioid agonist, to persons who are incarcerated in jail or prison. 12. Reentry Programs. Support programs that connect incarcerated persons to addiction treatment, recovery support, harm reduction services, primary healthcare, or other services or supports they need upon release from jail or prison, or that provide any of these services or supports. Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Exhibit B: Scope of Services Project Description and Program Sustainability (28 points, page limit: not to exceed 3 pages) Freedom House Recovery Center is submitting this proposal under Option A, Implementation Strategy 10: Criminal Justice Diversion Programs to support pre-arrest or post-arrest diversion programs and pre-trial services for justice involved individuals with SUD and OUD. In partnership with CJRD, Freedom House will continue working on Lantern Project to provide evidence-based addiction treatment, recovery support, harm reduction services, housing support, employment related services, peer support services and ongoing outpatient treatment for justice involved individuals in Orange County. The Lantern Project has consistently worked to increase the number of justice involved individuals with a history of opioid use who are connected to proper treatment -particularly among marginalized populations. FHRC employs a full-time licensed clinician and a Certified Peer Support Specialist (PSS) to work with Lantern Project to divert individuals with SUD from the Orange County justice system and jail into substance misuse treatment, which could be a more appropriate path to stifle continued justice involvement. FHRC also helps decrease the number of opioid overdoses as individuals enter treatment immediately from jail engaging with the supportive care needed to avoid relapses among those recently released from incarceration. CJRD collaborates with the magistrate and district attorney to identify low level offenders who have a history of substance use. Clients who are screened as eligible for enrollment with Lantern Project are referred to Freedom House with client consent for ongoing treatment. Our clinician then visits the individual while incarcerated to engage the potential client for further assessment. Then, if appropriate, the licensed clinician will refer the client to a FHRC Peer Support Specialist (PSS) to begin supporting the client in preparing for their next steps following release from jail. Individuals referred to Freedom House begin their journey by meeting with a licensed clinician for a clinical assessment. The assessment allows the clinician to gain an understanding of the client's history, current needs, and wants, as well as make a treatment recommendation based on the client's needs. Clinicians are trained to use the evidence-based practice of Motivational Interviewing (Ml) to help each client recognize their overarching desire for change and to expose any ambivalence towards change. Ml allows clients to progress at their own pace while addressing barriers that may present during the assessment process. Following the clinical assessment, and once the client is released from jail, the Peer Support Specialist helps facilitate the next steps, including an appointment with the Psychiatric Mental Health Nurse Practitioner (PMHNP) for medical assessment. The PMHNP will meet with the client to determine if medication such as Buprenorphine or Naltrexone is the best course of treatment for the client. When appropriate, the client will be scheduled for their first dose to begin evidence-based Medication Assisted Treatment (MAT) in combination with counseling and behavioral health therapies to treat opioid use disorders (OUD). Clients who come to Freedom House already on MAT are screened by the PMHNP to ensure the safe continuation of MAT services. As part of the clinical assessment process, the clinician will also assess individuals with a history of addiction who are re- entering the community from prison for enrollment in treatment services including Seeking Safety therapy, an evidence- based treatment that helps people with trauma, posttraumatic stress disorder, and substance misuse. Seeking Safety (SS) is a coping skills approach to help people reach safety from trauma and/or addiction. It is present-focused and designed to be safe, optimistic, and engaging. The treatment is highly flexible which allows clients to join the group at any point in the program and stay engaged through completion of all sections. It can be used early in the treatment process as it is stabilization oriented. If substance use halfway housing is determined to be a need for the client, they can begin the enrollment process for the halfway house. Enrollment includes the Halfway House Manager, who has QP credentials, collaborating with the client to develop a person-centered treatment plan. The treatment plan includes the goals and objectives the client would like to achieve while living in this supportive environment. The substance use halfway house is a structured, six-month Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 residential program that is staffed 24 hours a day, seven days per week by trained and certified Peers who help the client solve problems, connect to resources, and stabilize their mental and physical health. Peers also facilitate evidence-based practices such as Wellness Recovery Action Planning (WRAP), Wellness, Management and Recovery (WMR), and other life skills groups to help clients develop critical living and coping skills. The interdisciplinary treatment team and the client work together to ensure the strategies implemented are working for the client. The team meets weekly to evaluate each client's progress towards their recovery goals, behavioral health goals, physical health goals, and activities of daily living goals. When appropriate, the goals will be updated or changed as they are achieved or as the client becomes clearer about their desires for the future. FHRC takes recovery as a step-by-step process that includes several small victories in route to the goal of long-term recovery and stability. The FHRC clinician and PSS will also serve as liaison between FHRC and the CJRD staff. With proper consents in place, the FHRC clinician and PSS will advise CJRD of each Lantern client's progress towards their goals and assist with tracking outcomes. The FHRC staff will communicate with CJRD weekly via scheduled case conferences, or as needed, to review each client's care and progress throughout treatment. CJRD will also communicate with FHRC as needed to convey new referrals and to update the FHRC clinician and PSS on each client's status around court involvement/appearances. FHRC PSS also aids the client in adhering to court ordered appearances and/or conditions. FHRC maintains a team approach to serving justice involved clients. During weekly team meetings the interdisciplinary team will discuss the needs and challenges faced by clients to connect them with a broader service array. The treatment team discussion can begin when the client engages with FHRC clinician regardless of whether they are still incarcerated or living in the community. In the treatment team meeting is where the FHRC staff discuss the unmet needs of their current or soon to be released clients. The Lantern PPS and clinician also work to ensure that in addition to treatment, we address the social determinants of health as well. This includes ensuring the client is enrolled in Medicaid so they can see a physician, the client is connected to proper housing and food options, helping with job skills training and/or employment opportunities as well as other identified needs. As with all our clients, FHRC encourages ongoing connection to some level of treatment support for up to 12 months - which most experts agree is the length of time recommended for "sustained recovery" exemplified by significant improvements in life functioning and decreased incidents of relapse. Freedom House has been working with CJRD on Lantern Project for four years. The North Carolina Overdose Epidemic data from the Injury and Violence Prevention Branch of the North Carolina Division of Public Health reflects the positive outcomes occurring across Orange County in the efforts to overcome the opioid epidemic. Most recent data show Orange County has recorded a drop in Fentanyl Positive Deaths 2024 YTD to 11 which represents a decrease from the high of 28 in 2021. In addition, the estimated rate of Overdose Deaths in Orange County in 2023 was 21.0 out of 100,000 residents. This rate is a decrease from the 36 out of 100,000 residents in 2022 who died of overdose in Orange County. These statistics also stand for the realization of the Freedom House vision that all seeking recovery are connected to the care and resources they need to reach their fullest potential. We work towards this vision daily because we believe all are worthy of a full life in recovery and that hope in recovery awaits all who seek it. FHRC currently has a full-time licensed clinician and peer support dedicated to the Lantern Project. As we continue to expand the program and our support of justice involved individuals, we will increase engagement in ongoing recovery groups for graduates of the program. We will also look to begin providing Seeking Safety support for individuals while incarcerated. This evidence-based curriculum is designed to be used one on one or in a group setting. Incorporating this into our treatment opens the possibility of engaging added justice involved individuals in various settings with the goal of ongoing engagement upon release from incarceration. Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Overall Program Budget Agency Freedom House Recovery Center, Inc. Proposed Program Title Lantern Project Project Period Total Revenues:Opioid Settlement Funds Other Funding Sources Total Opioid Settlement Funds Other Funding Sources Total Opioid Settlement Funds Other Funding Sources Total Orange County Opioid Settlement Funding $ - $ - -$ $ - $ - $ - -$ $ - $ - $ - -$ $ - $ - $ - -$ $ - $ - $ - -$ $ - $ - $ - -$ Total Revenues: $ - $ - $ - $ - $ - $ - $ - $ - $ - -$ Project Period Total Expenses:Opioid Settlement Funds Other Funding Sources Total Opioid Settlement Funds Other Funding Sources Total Opioid Settlement Funds Other Funding Sources Total Personnel and Benefits: 60,400 60,400 - - - - 60,400 Operations Expenses: 6,023 6,023 - - - - 6,023 Subcontractor Services: Subcontractor 1 name - - - - - - - Subcontractor 2 name - - - - - - - Subcontractor 3 name - - - - - - - Capital - - - - Administrative/Indirect cost (no more than 10%) - - - - - Total Expenses: 66,423 - 66,423 - - - - - - 66,423 Total Program Expense Budget 2025 2026 2027 Complete this form for all revenue sources, as well as expense sources other than Opioid Settlement funds. Figures for expenses using Opioid Settlement funds will automatically populate from detail tabs of spreadsheet, except for the administrative/indirect cost line item, which should be filled out in this tab. Add rows as needed. Enter information in yellow shaded cells only. Total Program Revenue Budget 2025 2026 2027 Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Freedom House updated budget.xlsx Opioid Settlement Strategies RFA Budget Narrative Agency Proposed Program Title Year 2025 Year 2026 Year 2027 Direct Personnel and Fringe Benefits Direct Personnel and Fringe Benefits Direct Personnel and Fringe Benefits Other Direct Costs (Non-Personnel)Other Direct Costs (Non-Personnel)Other Direct Costs (Non-Personnel) Subcontractor/Consultant Services Subcontractor/Consultant Services Subcontractor/Consultant Services Administrative Costs Administrative Costs Administrative Costs Freedom House Recovery Center, Inc. Lantern Project The licensed clinician will conduct a Comprehensive Clinical Assessment to ascertain the best treatment options for the individual prior to or upon release from incarceration. Freedom House will utilize a Peer Support Specialist post incarceration to assist individuals with connecting to the recommended treatment. The Peer will work with the individual as long as needed to connect them with treatment, community resources, court appearances and to support the individual in recovery to curb recidivism. The clinician will reevaluate as needed when and if life circumstances change prior to engaging in treatment. See "OperationsDetail" tab. Narrative Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Freedom House updated budget.xlsx Operating Expenses Organization Name Freedom House Recovery Center, Inc. Project Title Lantern Project Line Item Year 1 amount Year 2 amount Year 3 amount Total Justification: detail calculations for line item for each year. Descriptions for purpose of line items should be detailed in the "Narrative" sheet. Supplies and Materials (Incentives, office needs, harm reduction materials, etc) -$ -$ -$ -$ -$ -$ Equipment (Cell Phone expenses, etc) Cell Phones 600.00$ 600.00$ The monthly phone expense for one staff person is $50. ($50*12 months) = $600 -$ -$ -$ -$ Travel Mileage 5,423.00$ 5,423.00$ The Lantern staff will travel approximately 8,279 miles annually. The reimbursement rate per mile is $.655. (8,279*$.655=$5,423) Training expenses Airfare -$ Lodging -$ Meals -$ Ground transportation -$ Parking -$ Rent Example: Office space -$ Example: $1,000 total monthly rent * 100 sq ft/1,000 sq feet total of office space used for this project * 12 months = $1,200 per year. Costs anticipated to be the same across all 3 project years Example: Equipment -$ -$ Utilities -$ -$ -$ -$ Media/Communications -$ -$ -$ Staff development/Training Staff Training -$ -$ -$ Professional Services Example: Audit services -$ Example: IT -$ -$ -$ Other -$ -$ -$ 6,023.00$ -$ -$ 6,023.00$ Complete this form such that amounts for County Opioid Settlement Funds are shown when entering line item detail. Add rows as needed. Enter information in yellow shaded cells only. OperationsDetail Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Attachment A Start Date: 7/1/2025 End Date: 6/30/2026 Description Count How were efforts supported?Notes Additional Information & Helpful Hints about this Measure # of 911 calls with primary concern related to substance use # of dispositions where person was transported to services by law enforcement # of dispositions where person was stabilized in community # of arrest diversion referrals to pre-arrest diversion programs by law enforcement # of social referrals to pre-arrest diversion programs by law enforcement # of intakes for pre-arrest diversion programs completed # of unique participants enrolled in pre-arrest diversion programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of full-time pre-arrest diversion program staff # of participants on staff caseload (average) # of contacts with pre-arrest diversion program participants # of people arrested who are screened for OUD # of referrals to post-arrest diversion programs by jail/correctional staff # of intakes for post-arrest diversion programs completed # of unique participants enrolled in post-arrest diversion programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of dedicated post-arrest diversion program staff # of contacts with post-arrest diversion program participants # of people at intake with no fixed address or address is shelter # of referrals to pre-trial service programs by court staff # of intakes for pre-trial service programs completed # of unique participants enrolled in pre-trial service programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of contacts with pre-trial service program participants # of initial hearings annually for people identified as having opioid use disorder # of participants who use opioids and/or have OUD, referred to addiction treatment # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of participants who use opioids and/or have OUD, referred to harm reduction services (e.g., syringe and supply access, overdose prevention education, disease prevention, etc.) # of participants who use opioids and/or have OUD, referred to primary healthcare # of participants who use opioids and/or have OUD, referred to other services # of participants who use opioids and/or have OUD, provided addiction treatment # of participants who use opioids and/or have OUD, provided with recovery support services (e.g., employment services, housing services, etc.) # of participants who use opioids and/or have OUD, provided with harm reduction services # of participants who use opioids and/or have OUD, provided with primary healthcare services # of participants who use opioids and/or have OUD, provided with other services # of naloxone kits provided Custom, strategy-specific measures may be entered in this row. Custom, strategy-specific measures may be entered in this row. Custom, strategy-specific measures may be entered in this row. Process Measure Count Additional Information & Helpful Hints about this Measure # of unique participants, who use opioids and/or have OUD, served American Indian/Alaska Native Non-Hispanic Asian Non-Hispanic Black Non-Hispanic Native Hawaiian or Other Pacific Islander Non-Hispanic White Non-Hispanic Hispanic Some Other Race or Multiple Races Unknown Sum total of unique participants served (Autocalculated) Does sum total (C65) match the reported # of unique patients (C55)? (Autocalculated)Yes 10. Criminal Justice Diversion Insert Start and End Date for this Strategy (MM/DD/YYYY) Process measures answer the question, “How much did you do?”. Please quantify the process measures relevant to your implementation of this strategy. Indicate whether the count represents efforts supported only by opioid settlement funds or efforts supported by multiple funding sources including opioid settlement funds. Process measures should reflect numbers from the current reporting period (fiscal year). STRATEGY-SPECIFIC PROCESS MEASURES STRATEGY-SPECIFIC QUALITY MEASURES Quality measures answer the question, “How well did you do it?”. Please quantify the quality measures relevant to your implementation of this strategy. Quality measures should reflect numbers from the current reporting period (fiscal year). DEMOGRAPHICS: Provide the following information on race and ethnicity for the # of unique participants, who use opioids and/or have OUD, served during the current reporting period (fiscal year). Notes Of the # of unique participants, who use opioids and/or have OUD, served in the count above, how many people identified as: Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Description Count Quality Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure # of unique participants, who use opioids and/or have OUD, served, who report they are satisfied with services # of unique participants, who use opioids and/or have OUD, served # of 911 calls with primary concern related to substance use # of 911 calls # of people arrested who screen positive for OUD # of people arrested who are screened for OUD # of law enforcement officers who have referred to diversion program # of law enforcement officers # of unique participants, who use opioids and/or have OUD, served, who are connected to services # of unique participants, who use opioids and/or have OUD, served # of unique participants, who use opioids and/or have OUD, served, who have been provided with services # of unique participants, who use opioids and/or have OUD, served Description Count Outcome Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure # of referrals that resulted in enrollment in diversion program # of referrals to diversion programs # of unique participants with OUD who were connected to treatment and have adhered to treatment # of unique participants who have OUD who were connected to treatment (i.e. attended their first appointment) # of participants who have obtained employment at 6 months # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of participants who retain housing at 6 months # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of unique participants with OUD served who were referred to harm reduction services and remained engaged with harm reduction services # of participants who use opioids and/or have OUD, referred to harm reduction services (e.g., syringe and supply access, overdose prevention education, disease prevention, etc.) # of participants with OUD using primary healthcare services at 6 months # of participants who use opioids and/or have OUD, referred to primary healthcare # of participants with OUD using other services at 6 months # of participants who use opioids and/or have OUD, referred to other services # of community overdose reversals using naloxone # of community overdose reversals using naloxone N/A A community overdose reversal is one where naloxone is administered by a community member who is not EMT or first responder staff. Description Notes Additional Information & Helpful Hints about this Measure % of residents receiving dispensed buprenorphine prescriptions The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population-Level) and "Place" to find your county. Treatment services rate per 100,000 residents, representing # of uninsured people and Medicaid beneficiaries who received treatment for OUD The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population-Level) and "Place" to find your county. Overdose death rate per 100,000 residents The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population- Level) and "Place" to find your county. Overdose emergency department visits per 100,000 residents The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population- Level) and "Place" to find your county. Start Date: 1/0/1900 End Date: 1/0/1900 Description Count How were efforts supported?Notes Additional Information & Helpful Hints about this Measure # of 911 calls with primary concern related to substance use # of dispositions where person was transported to services by law enforcement # of dispositions where person was stabilized in community # of arrest diversion referrals to pre-arrest diversion programs by law enforcement # of social referrals to pre-arrest diversion programs by law enforcement # of intakes for pre-arrest diversion programs completed % of participants, who use opioids and/or have OUD, who are satisfied w/ services Incomplete % of participants connected to services Incomplete % of people arrested who screen positive for OUD Incomplete % of 911 calls related to substance use concerns Incomplete % of law enforcement officers who have referred to diversion program Incomplete Incomplete Custom, strategy-specific measures may be entered in this row. Incomplete Custom, strategy-specific measures may be entered in this row. % of participants provided with services Incomplete Incomplete Custom, strategy-specific measures may be entered in this row. % of participants with OUD who adhere to treatment 6 months after first appointment Incomplete Recommended measure at six months. If measure for adherence is taken at another increment, please describe this in the "Notes" column. For recommendations on how to report 6-month adherence, please visit this link. % of participants who have obtained/retained employment at 6 months Incomplete Recommended measure at six months. If measure for employment is taken at another increment, please describe this in the "Notes" column. Outcome measures answer the question, “Is anyone better off?”. Outcome measures can be at the program- or population-level. Please quantify the outcome measures relevant to your implementation of this strategy. Outcome measures should reflect numbers from the current reporting period (fiscal year). STRATEGY-SPECIFIC OUTCOME MEASURES (PROGRAM-LEVEL) % of referrals that resulted in enrollment in diversion program Incomplete % of participants using primary healthcare services at 6 months Incomplete Recommended measure at six months. If measure for utilization is taken at another increment, please describe this in the "Notes" column. % of participants using other services at 6 months Incomplete Recommended measure at six months. If measure for utilization is taken at another increment, please describe this in the "Notes" column. % of participants who obtained/retained housing at 6 months Incomplete Recommended measure at six months. If measure for retention of permanent housing is taken at another increment, please describe this in the "Notes" column. % of participants engaged with harm reduction services at 6 months Incomplete Recommended measure at six months. If measure for engagement is taken at another increment, please describe this in the "Notes" column. Incomplete Custom, strategy-specific measures may be entered in this row. In addition to any program-level outcome measures captured above, population-level data on outcome measures are available from the NC Overdose Epidemic Data Dashboard. Please visit the Data Dashboard and become familiar with what is available. Then indicate if there are population-level outcome measures you are expecting to change as a result of your implementation of this strategy. The NC Overdose Epidemic Data Dashboard provides integration and visualization of state, regional, and county-level metrics for partners across NC to track progress toward reaching common goals. Which metrics are shared on the Dashboard, referred to as outcome measures (population-level) in the Impact Report, may change over time. Incomplete Custom, strategy-specific measures may be entered in this row. Incomplete Custom, strategy-specific measures may be entered in this row. 10. Criminal Justice Diversion Insert Start and End Date for this Strategy (MM/DD/YYYY) Process measures answer the question, “How much did you do?”. Please quantify the process measures relevant to your implementation of this strategy. Indicate whether the count represents efforts supported only by opioid settlement funds or efforts supported by multiple funding sources including opioid settlement funds. Process measures should reflect numbers from the current reporting period (fiscal year). STRATEGY-SPECIFIC PROCESS MEASURES STRATEGY-SPECIFIC OUTCOME MEASURES (POPULATION-LEVEL) Are you expecting to change this measure as a result of implementing this strategy? Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 # of unique participants enrolled in pre-arrest diversion programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of full-time pre-arrest diversion program staff # of participants on staff caseload (average) # of contacts with pre-arrest diversion program participants # of people arrested who are screened for OUD # of referrals to post-arrest diversion programs by jail/correctional staff # of intakes for post-arrest diversion programs completed # of unique participants enrolled in post-arrest diversion programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of dedicated post-arrest diversion program staff # of contacts with post-arrest diversion program participants # of people at intake with no fixed address or address is shelter # of referrals to pre-trial service programs by court staff # of intakes for pre-trial service programs completed # of unique participants enrolled in pre-trial service programs This process measure indicates how many unique individuals are served by this strategy. We understand that in some circumstances there will be duplication in this number. A unique participant may participate in multiple support programs so there may be duplication of unique participants when numbers across programs, project, sites, etc., are aggregated for this strategy. There may be some duplication across strategies too. For example, a unique individual may receive services from a Criminal Justice Diversion Program and a Recovery Support Services provider. That participant may be counted in the number you provide in the Criminal Justice Diversion Programs tab and in the number you provide in the Recovery Support Services tab. A participant may receive services across local government boundaries (e.g., a person with OUD may reside in one county and receive services in another county). Number of screenings/referrals for, or calls to, a person do not equate to number of unique participants because one individual may receive multiple screenings/referrals/calls. # of contacts with pre-trial service program participants # of initial hearings annually for people identified as having opioid use disorder # of participants who use opioids and/or have OUD, referred to addiction treatment # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of participants who use opioids and/or have OUD, referred to harm reduction services (e.g., syringe and supply access, overdose prevention education, disease prevention, etc.) # of participants who use opioids and/or have OUD, referred to primary healthcare # of participants who use opioids and/or have OUD, referred to other services # of participants who use opioids and/or have OUD, provided addiction treatment # of participants who use opioids and/or have OUD, provided with recovery support services (e.g., employment services, housing services, etc.) # of participants who use opioids and/or have OUD, provided with harm reduction services # of participants who use opioids and/or have OUD, provided with primary healthcare services # of participants who use opioids and/or have OUD, provided with other services # of naloxone kits provided Custom, strategy-specific measures may be entered in this row. Custom, strategy-specific measures may be entered in this row. Custom, strategy-specific measures may be entered in this row. Process Measure Count Additional Information & Helpful Hints about this Measure # of unique participants, who use opioids and/or have OUD, served American Indian/Alaska Native Non-Hispanic Asian Non-Hispanic Black Non-Hispanic Native Hawaiian or Other Pacific Islander Non-Hispanic White Non-Hispanic Hispanic Some Other Race or Multiple Races Unknown Sum total of unique participants served (Autocalculated) Does sum total (C65) match the reported # of unique patients (C55)? (Autocalculated)Yes Description Count Quality Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure # of unique participants, who use opioids and/or have OUD, served, who report they are satisfied with services # of unique participants, who use opioids and/or have OUD, served # of 911 calls with primary concern related to substance use # of 911 calls # of people arrested who screen positive for OUD # of people arrested who are screened for OUD # of law enforcement officers who have referred to diversion program # of law enforcement officers # of unique participants, who use opioids and/or have OUD, served, who are connected to services # of unique participants, who use opioids and/or have OUD, served # of unique participants, who use opioids and/or have OUD, served, who have been provided with services # of unique participants, who use opioids and/or have OUD, served DEMOGRAPHICS: Provide the following information on race and ethnicity for the # of unique participants, who use opioids and/or have OUD, served during the current reporting period (fiscal year). Notes Of the # of unique participants, who use opioids and/or have OUD, served in the count above, how many people identified as: % of 911 calls related to substance use concerns Incomplete % of people arrested who screen positive for OUD Incomplete Quality measures answer the question, “How well did you do it?”. Please quantify the quality measures relevant to your implementation of this strategy. Quality measures should reflect numbers from the current reporting period (fiscal year). STRATEGY-SPECIFIC QUALITY MEASURES % of participants, who use opioids and/or have OUD, who are satisfied w/ services Incomplete % of participants provided with services Incomplete Incomplete Custom, strategy-specific measures may be entered in this row. % of law enforcement officers who have referred to diversion program Incomplete % of participants connected to services Incomplete Incomplete Custom, strategy-specific measures may be entered in this row. Incomplete Custom, strategy-specific measures may be entered in this row. Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Description Count Outcome Measure Percent (Autocalculated)Notes Additional Information & Helpful Hints about this Measure # of referrals that resulted in enrollment in diversion program # of referrals to diversion programs # of unique participants with OUD who were connected to treatment and have adhered to treatment # of unique participants who have OUD who were connected to treatment (i.e. attended their first appointment) # of participants who have obtained employment at 6 months # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of participants who retain housing at 6 months # of participants who use opioids and/or have OUD, referred to recovery supports (e.g., employment services, housing services, etc.) # of unique participants with OUD served who were referred to harm reduction services and remained engaged with harm reduction services # of participants who use opioids and/or have OUD, referred to harm reduction services (e.g., syringe and supply access, overdose prevention education, disease prevention, etc.) # of participants with OUD using primary healthcare services at 6 months # of participants who use opioids and/or have OUD, referred to primary healthcare # of participants with OUD using other services at 6 months # of participants who use opioids and/or have OUD, referred to other services # of community overdose reversals using naloxone # of community overdose reversals using naloxone N/A A community overdose reversal is one where naloxone is administered by a community member who is not EMT or first responder staff. Description Notes Additional Information & Helpful Hints about this Measure % of residents receiving dispensed buprenorphine prescriptions The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population-Level) and "Place" to find your county. Treatment services rate per 100,000 residents, representing # of uninsured people and Medicaid beneficiaries who received treatment for OUD The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population-Level) and "Place" to find your county. Overdose death rate per 100,000 residents The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population- Level) and "Place" to find your county. Overdose emergency department visits per 100,000 residents The North Carolina Overdose Epidemic Data Dashboard can be found here. Use the "Metrics" dropdown to find the "Metric" (i.e., Outcome Measure, Population- Level) and "Place" to find your county. Outcome measures answer the question, “Is anyone better off?”. Outcome measures can be at the program- or population-level. Please quantify the outcome measures relevant to your implementation of this strategy. Outcome measures should reflect numbers from the current reporting period (fiscal year). STRATEGY-SPECIFIC OUTCOME MEASURES (PROGRAM-LEVEL) % of referrals that resulted in enrollment in diversion program Incomplete % of participants who obtained/retained housing at 6 months Incomplete Recommended measure at six months. If measure for retention of permanent housing is taken at another increment, please describe this in the "Notes" column. % of participants engaged with harm reduction services at 6 months Incomplete Recommended measure at six months. If measure for engagement is taken at another increment, please describe this in the "Notes" column. % of participants with OUD who adhere to treatment 6 months after first appointment Incomplete Recommended measure at six months. If measure for adherence is taken at another increment, please describe this in the "Notes" column. For recommendations on how to report 6-month adherence, please visit this link. % of participants who have obtained/retained employment at 6 months Incomplete Recommended measure at six months. If measure for employment is taken at another increment, please describe this in the "Notes" column. Incomplete Custom, strategy-specific measures may be entered in this row. Incomplete Custom, strategy-specific measures may be entered in this row. % of participants using primary healthcare services at 6 months Incomplete Recommended measure at six months. If measure for utilization is taken at another increment, please describe this in the "Notes" column. % of participants using other services at 6 months Incomplete Recommended measure at six months. If measure for utilization is taken at another increment, please describe this in the "Notes" column. STRATEGY-SPECIFIC OUTCOME MEASURES (POPULATION-LEVEL) Are you expecting to change this measure as a result of implementing this strategy? Incomplete Custom, strategy-specific measures may be entered in this row. In addition to any program-level outcome measures captured above, population-level data on outcome measures are available from the NC Overdose Epidemic Data Dashboard. Please visit the Data Dashboard and become familiar with what is available. Then indicate if there are population-level outcome measures you are expecting to change as a result of your implementation of this strategy. The NC Overdose Epidemic Data Dashboard provides integration and visualization of state, regional, and county-level metrics for partners across NC to track progress toward reaching common goals. Which metrics are shared on the Dashboard, referred to as outcome measures (population-level) in the Impact Report, may change over time. Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479 Docusign Envelope ID: FB53EE36-9A37-4A41-B6E0-570BEA11D479